Brainstorm Cell Therapeutics (BCLI) Depreciation & Amortization (CF) (2010 - 2026)
Brainstorm Cell Therapeutics' Depreciation & Amortization (CF) came in at $46,000 for Q2 2026, down 9.8% from $51,000 a year earlier but up 24.3% from the prior quarter.
Powered by 
Analysis
Brainstorm Cell Therapeutics (BCLI) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Brainstorm Cell Therapeutics reported Depreciation & Amortization (CF) of $179,000, down 16.7% year-over-year; for FY2025, it came in at $199,000, down 17.1% from FY2024.
- Depreciation & Amortization (CF) has declined in each of the last three years, with a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $240,000 in FY2024 (-9.4%), $265,000 in FY2023 (-7.0%), $285,000 in FY2022 (+9.6%) and $260,000 in FY2021 (+18.7%).
- The five-year range for quarterly Depreciation & Amortization (CF) is $37,000 (Q1 2026) to $74,000 (Q1 2022).
- Year-over-year, Depreciation & Amortization (CF) has declined for 14 consecutive quarters, with an average decline of 16.8% over the last eight quarters.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2022 (growth of 21.3%), and the weakest in Q1 2026 (a decline of 28.8%).
- Business Quant data shows BCLI's Depreciation & Amortization (CF) at $37,000 (Q1 2026), $48,000 (Q4 2025) and $48,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Brainstorm Cell Therapeutics | 8.50 Mn | 8.43 Mn | - | 46,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46,000.00 |
| Mar 31, 2026 | 37,000.00 |
| Dec 31, 2025 | 48,000.00 |
| Sep 30, 2025 | 48,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 52,000.00 |
| Dec 31, 2024 | 53,000.00 |
| Sep 30, 2024 | 59,000.00 |
| Jun 30, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 66,000.00 |
| Sep 30, 2023 | 65,000.00 |
| Jun 30, 2023 | 67,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 70,000.00 |
| Sep 30, 2022 | 70,000.00 |
| Jun 30, 2022 | 71,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Sep 30, 2021 | 67,000.00 |
API Access
Brainstorm Cell Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BCLI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "BCLI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=BCLI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();